Compound Prioritization in Single-Concentration Screening Data Using Ligand Efficiency Indexes

Journal of Chemical Information and Modeling

Volumn 56, Issue 9, 2016, Pages 1705-1713

  Colmenarejo, Gonzalo ^a  

^a Molecular Discovery Research   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; CORRELATION METHODS; DRUG PRODUCTS; EFFICIENCY; MULTIOBJECTIVE OPTIMIZATION; PHYSICOCHEMICAL PROPERTIES;

AREAS UNDER THE CURVES; DOSE-RESPONSE CURVES; EFFICIENCY PARAMETERS; HIGH-THROUGHPUT SCREENING; PEARSON'S CORRELATION COEFFICIENTS; PHYSICOCHEMICAL PARAMETERS; RECEIVER OPERATING CHARACTERISTIC CURVES; SCREENING TECHNOLOGY;

LIGANDS;

LIGAND;

COST BENEFIT ANALYSIS; DOSE RESPONSE; ECONOMICS; IC50; PRECLINICAL STUDY; PROCEDURES;

COST-BENEFIT ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; INHIBITORY CONCENTRATION 50; LIGANDS;

EID: 84988841687     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/acs.jcim.6b00299     Document Type: Article

References (18)

1. Macarron, R.; Banks, M. N.; Bojanic, D.; Burns, D. J.; Cirovic, D. A.; Garyantes, T.; Green, D. V.; Hertzberg, R. P.; Janzen, W. P.; Paslay, J. W.; Schopfer, U. et al. Impact of High-Throughput Screening in Biomedical Research Nat. Rev. Drug Discovery 2011, 10, 188-195 10.1038/nrd3368
2. Hann, M. M. Molecular Obesity, Potency and Other Addictions in Drug Discovery MedChemComm 2011, 2, 349-355 10.1039/c1md00017a
3. Hopkins, A. L.; Keserü, G. M.; Leeson, P. D.; Rees, D. C.; Reynolds, C. H. The Role of Ligand Efficiency Metrics in Drug Discovery Nat. Rev. Drug Discovery 2014, 13, 105-121 10.1038/nrd4163
4. Hopkins, A. L.; Groom, C. R.; Alex, A. Ligand Efficiency: a Useful Metric for Lead Selection Drug Discovery Today 2004, 9, 430-431 10.1016/S1359-6446(04)03069-7
5. Kuntz, I. D.; Chen, K.; Sharp, K. A.; Kollman, P. A. The Maximal Affinity of Ligands Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 9997-10002 10.1073/pnas.96.18.9997
6. Leeson, P. D.; Springthorpe, B. The Influence of Drug-Like Concepts on Decision-Making in Medicinal Chemistry Nat. Rev. Drug Discovery 2007, 6, 881-890 10.1038/nrd2445
7. Leach, A. R.; Hann, M. M.; Burrows, J. N.; Griffen, E. J. Fragment Screening: an Introduction Mol. BioSyst. 2006, 2, 429-446 10.1039/b610069b
8. Mortenson, P. N.; Murray, C. W. Assessing the Lipophilicity of Fragments and Early Hits J. Comput.-Aided Mol. Des. 2011, 25, 663-667 10.1007/s10822-011-9435-z
9. Abad-Zapatero, C.; Metz, J. T. Ligand Efficiency Indices as Guideposts for Drug Discovery Drug Discovery Today 2005, 10, 464-469 10.1016/S1359-6446(05)03386-6
10. R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria, 2014. http://www.R-project.org (accessed May 1, 2016).
11. Robin, X.; Turck, N.; Hainard, A.; Tiberti, N.; Lisacek, F.; Sanchez, J. C.; Muller, M. pROC: an Open-Source Package for R and S+ to Analyze and Compare ROC curves BMC Bioinf. 2011, 12, 77 10.1186/1471-2105-12-77
12. TIBCO Spotfire, version 7.6; TIBCO Software Inc.: Boston, 2016.
13. Butina, D. Unsupervised Data Base Clustering Based on Daylight's Fingerprint and Tanimoto Similarity: A Fast and Automated Way To Cluster Small and Large Data Sets J. Chem. Inf. Comp. Sci. 1999, 39, 747-750 10.1021/ci9803381
14. Landrum, G. RDKit: Open-Source Cheminformatics. Version 2013.03.1. http://rdkit.org/ (accessed March 2015).
15. Lantz, B. Evaluating Model Performance. In Machine Learning with R; Pack Publishing: Birmingham 2013, 313
16. Dahlin, J. L.; Walters, M. A. The Essential Roles of Chemistry in High-Throughput Screening Triage Future Med. Chem. 2014, 6, 1265-1290 10.4155/fmc.14.60
17. Kenny, P. W.; Leitao, A.; Montanari, C. A. Ligand Efficiency Metrics Considered Harmful J. Comput.-Aided Mol. Des. 2014, 28, 699-710 10.1007/s10822-014-9757-8
18. Reynolds, C. H. Ligand Efficiency Metrics: Why All the Fuss? Future Med. Chem. 2015, 7, 1363-1365 10.4155/fmc.15.70